Management of Unusual Cutaneous Malignancies: Atypical Fibroxanthoma, Malignant Fibrous Histiocytoma, Sebaceous Carcinoma, Extramammary Paget Disease

被引：28
作者：
Love, W. Elliot [1 ]
Schmitt, Adam R. [2 ]
Bordeaux, Jeremy S. [3 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Dept Dermatol, MetroHlth Med Ctr, Pepper Pike, OH 44122 USA
[2] Case Western Reserve Univ, Sch Med, Dept Dermatol, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Dermatol, Univ Hosp Case Med Ctr, Orange Village, OH 44122 USA
来源：
DERMATOLOGIC CLINICS | 2011年 / 29卷 / 02期
关键词：
Atypical fibroxanthoma; Malignant fibrous histiocytoma; Sebaceous carcinoma; Extramammary Paget disease; Skin cancer; MOHS MICROGRAPHIC SURGERY; OF-THE-LITERATURE; SQUAMOUS-CELL CARCINOMA; SOFT-TISSUE SARCOMAS; MUIR-TORRE SYNDROME; SPINDLE-CELL; WIDE EXCISION; FIBROHISTIOCYTIC TUMORS; SURGICAL-TREATMENT; GLAND CARCINOMA;
D O I：
10.1016/j.det.2011.02.007
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Atypical fibroxanthoma, malignant fibrous histiocytoma, sebaceous carcinoma, and extramammary Paget disease are rare cutaneous tumors. Their recognition and diagnosis are critical in decreasing long-term morbidity and mortality. Surgical excision is the treatment of choice for these tumors, and Mohs micrographic surgery has been shown to be as favorable or better than wide local excision in providing long-term clearance rates.
引用
收藏
页码：201 / +
页数：17
相关论文
共 13 条
  • [1] Atypical fibroxanthoma/malignant fibrous histiocytoma
    Marcet, Seteven
    DERMATOLOGIC THERAPY, 2008, 21 (06) : 424 - 427
  • [2] Atypical fibroxanthoma and malignant fibrous histiocytoma
    Withers, Aaron H. J.
    Brougham, Nicholas D. L.
    Barber, Rachel M.
    Tan, Swee T.
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2011, 64 (11) : E273 - E278
  • [3] Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin
    Rizzardi, C
    Angiero, F
    Melato, M
    ANTICANCER RESEARCH, 2003, 23 (2C) : 1847 - 1851
  • [4] Recurrent Atypical Fibroxanthoma Versus Malignant Fibrous Histiocytoma
    Branch, Leslie G.
    Albertini, John G.
    Leshin, Barry
    JOURNAL OF CRANIOFACIAL SURGERY, 2015, 26 (04) : E322 - E323
  • [5] Apoptosis in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma
    Westermann, FN
    Langlois, NEI
    Simpson, JG
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1997, 19 (03) : 228 - 231
  • [6] Malignant fibrous histiocytoma and atypical fibroxanthoma in renal transplant recipients
    Hafner, J
    Künzi, W
    Weinrich, T
    DERMATOLOGY, 1999, 198 (01) : 29 - 32
  • [7] ATYPICAL FIBROXANTHOMA VERSUS BENIGN AND MALIGNANT FIBROUS HISTIOCYTOMA
    OSHIRO, Y
    FUKUDA, T
    TSUNEYOSHI, M
    CANCER, 1995, 75 (05) : 1128 - 1134
  • [8] Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma
    Sakamoto, A
    Oda, Y
    Itakura, E
    Oshiro, Y
    Nikaido, O
    Iwamoto, Y
    Tsuneyoshi, M
    MODERN PATHOLOGY, 2001, 14 (06) : 581 - 588
  • [9] H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma
    Sakamoto, A
    Oda, Y
    Itakura, E
    Oshiro, Y
    Tamiya, S
    Honda, Y
    Ishihara, A
    Iwamoto, Y
    Tsuneyoshi, M
    HUMAN PATHOLOGY, 2001, 32 (11) : 1225 - 1231
  • [10] LN-2 (CD74) - A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma
    Lazova, R
    Moynes, R
    May, D
    Scott, G
    CANCER, 1997, 79 (11) : 2115 - 2124
12